SPOTLIGHT: Novartis makes the "Biggest Splash"

Thompson Scientific has released "Who's making the Biggest Splash," a quarterly review of scientific literature on drugs and therapies. The report provides an objective assessment of the quantity and quality of materials published by pharmaceutical companies and other research institutions. According to the research firm, Novartis has snatched the lead from GSK, which has dominated the ranking since June of 2006. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.